Web-Based Mindfulness Intervention in Heart Disease: A Randomized Controlled Trial.
Study Goal
The researchers aimed to determine the beneficial physiological and psychological effects of online mindfulness training in patients with heart disease.
Results Summary
Mindfulness training showed a borderline significant improvement in exercise capacity (6MWT) and a significant reduction in heart rate, but no significant differences were observed in other physiological or psychological outcomes.
Population
324 patients with heart disease (mean age 43.2 years, 53.7% male).
Effective Dosage
Not specified
Duration
12 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
online mindfulness training | increase | exercise capacity measured with the 6 minute walk test (6MWT) | patients with heart disease | 13.2 meters (effect size) | showed a borderline significant improved | #1 |
online mindfulness training | decrease | heart rate | patients with heart disease | -2.8 beats per minute (effect size) | significant lower | #2 |
online mindfulness training | no change | other physiological parameters (blood pressure, respiratory rate, and NT-proBNP) | patients with heart disease | no significant change | No significant differences were seen | #3 |
online mindfulness training | no change | subjective health status (SF-36) | patients with heart disease | no significant change | No significant differences were seen | #4 |
online mindfulness training | no change | perceived stress (PSS) | patients with heart disease | no significant change | No significant differences were seen | #5 |
online mindfulness training | no change | psychological well-being (HADS) | patients with heart disease | no significant change | No significant differences were seen | #6 |
online mindfulness training | no change | social support (PSSS12) | patients with heart disease | no significant change | No significant differences were seen | #7 |
online mindfulness training | no change | composite endpoint (all-cause mortality, heart failure, symptomatic arrhythmia, cardiac surgery, and percutaneous cardiac intervention) | patients with heart disease | no significant change | No significant differences were seen | #8 |
BACKGROUND: Evidence is accumulating that mindfulness training has favorable effects on psychological outcomes, but studies on physiological outcomes are limited. Patients with heart disease have a high incidence of physiological and psychological problems and may benefit from mindfulness training. Our aim was to determine the beneficial physiological and psychological effects of online mindfulness training in patients with heart disease. METHODS: The study was a pragmatic randomized controlled single-blind trial. Between June 2012 and April 2014 we randomized 324 patients (mean age 43.2 years, 53.7% male) with heart disease in a 2:1 ratio (n = 215 versus n = 109) to a 12-week online mindfulness training in addition to usual care (UC) compared to UC alone. The primary outcome was exercise capacity measured with the 6 minute walk test (6MWT). Secondary outcomes were other physiological parameters (heart rate, blood pressure, respiratory rate, and NT-proBNP), subjective health status (SF-36), perceived stress (PSS), psychological well-being (HADS), social support (PSSS12) and a composite endpoint (all-cause mortality, heart failure, symptomatic arrhythmia, cardiac surgery, and percutaneous cardiac intervention). Linear mixed models were used to evaluate differences between groups on the repeated outcome measures. RESULTS: Compared to UC, mindfulness showed a borderline significant improved 6MWT (effect size, meters: 13.2, 95%CI: -0.02; 26.4, p = 0.050). There was also a significant lower heart rate in favor of the mindfulness group (effect size, beats per minute: -2.8, 95%CI: -5.4;-0.2, p = 0.033). No significant differences were seen on other outcomes. CONCLUSIONS: Mindfulness training showed positive effects on the physiological parameters exercise capacity and heart rate and it might therefore be a useful adjunct to current clinical therapy in patients with heart disease. TRIAL REGISTRATION: Dutch Trial Register 3453.